Medical Hyperspectral Imaging Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Hyperspectral Camera, Accessories), By Technology (Snapshot, Push Broom, Others), By Application (Medical Diagnostics, Quality Assurance & Drug Testing, Others), By End Use (Hospitals & Clinics, Research & Academic Institutes, Pharmaceutical and Biotechnology Companies) and Region Forecast 2020-2031

Medical hyperspectral imaging market size was valued at US$ 3,450.3 million in 2024 and is projected to reach US$ 7,771.7 million by 2031 at a CAGR of 12.3% from 2025-2031. Moreover, the U.S. Medical Hyperspectral Imaging Market is projected to grow at 12.2% over the forecast period.

The market refers to the industry focused on the development, production, and application of advanced imaging systems that capture a wide spectrum of light across numerous wavelengths for clinical and diagnostic use. Unlike conventional imaging technologies, hyperspectral imaging provides detailed spectral information at each pixel, enabling precise tissue characterization, disease detection, and improved surgical guidance. This market encompasses imaging systems, software, and accessories tailored for medical diagnostics, research, and surgical applications.

The market is experiencing steady growth, driven by rising demand for non-invasive diagnostic techniques and the increasing need for early disease detection. Its applications in oncology, ophthalmology, wound care, and surgical procedures are expanding as the technology offers real-time visualization and high diagnostic accuracy. Technological advancements, coupled with growing adoption in research institutions and hospitals, are fueling market expansion. However, high system costs and technical complexities remain challenges. Overall, the market is positioned for significant adoption as healthcare systems prioritize precision medicine and advanced imaging solutions.

Facts & Figures

• Europe has launched a new doctoral network called METRAMAT under the Horizon 2022 Marie Sklodowska-Curie Action, which has opened 10 PhD positions for researchers focused on Medical Hyperspectral Imaging development.
• In late 2024, a work on multifunctional passive metacrystals was published which demonstrated that dielectric Medical Hyperspectral Imaging composites could be designed to operate up to 100 GHz, provide multiple signal handling (polarization, angle, frequency), and be fabricated via accessible additive manufacturing methods.
• The number of scholarly articles on Medical Hyperspectral Imagings (and related fields like plasmonics) continues to rise: more than 7,000 papers were published in 2023 in special issues and journals focused on Medical Hyperspectral Imagings/plasmonics, up from far fewer in earlier years.

Key Developments

• In July 2025, Hypervision Surgical received FDA 510(k) clearance for its HYPERSNAP® Surgical System. This platform integrates hyperspectral imaging with AI-powered analytics to provide real-time surgical decision support, enhancing patient safety during procedures. It is the first intraoperative system to offer quantitative tissue oxygenation information through computational hyperspectral imaging in the visible spectrum.
• In April 2025, KARL STORZ acquired intellectual property and staff from Diaspective Vision, a company specializing in hyperspectral imaging systems. This acquisition includes the TIVITA Mini hyperspectral endoscopic system, which is used for non-contact tissue assessment. The move strengthens KARL STORZ's position in hyperspectral surgical applications and supports its development of advanced medical imaging technologies.
• In June 2025 Specim Americas partnered with NASA to develop space-grade hyperspectral imaging systems. These systems are intended for deployment in upcoming Earth observation missions, advancing climate research and space exploration. The collaboration underscores the growing significance of hyperspectral imaging in both medical and environmental applications.

Medical Hyperspectral Imaging Market Segmentation

Based on the product

• Hyperspectral Camera
• Accessories

Among the product segments, hyperspectral cameras are anticipated to lead the market, primarily due to their central role in capturing high-resolution spectral and spatial information required for clinical diagnostics. Hyperspectral cameras are the core hardware that enables non-invasive tissue characterization, real-time surgical guidance, and precise monitoring of physiological parameters such as oxygenation and perfusion. Their increasing use in oncology for tumor margin detection, ophthalmology for retinal disease assessment, and wound care for chronic ulcer evaluation highlights their dominance over accessories, which play a supportive role. The advancement of compact, portable, and high-speed hyperspectral cameras has also expanded their adoption in point-of-care settings, making them more practical for routine clinical use. Furthermore, integration with artificial intelligence enhances their diagnostic capabilities, providing physicians with immediate decision-making support. As hospitals and research institutions prioritize accuracy and efficiency in imaging, hyperspectral cameras remain the driving force behind market growth.

Based on the technology

• Snapshot
• Push Broom
• Others

Within the technology segment, the snapshot hyperspectral imaging approach is anticipated to lead the market, driven by its ability to capture an entire spectral data cube in a single acquisition. Unlike push broom technology, which requires scanning across the sample and can be time-consuming, snapshot systems provide real-time imaging without motion artifacts, making them particularly valuable in surgical and clinical environments. Surgeons benefit from the rapid acquisition of spectral information, enabling immediate assessment of tissue viability, perfusion, and disease margins during procedures. This speed and efficiency also make snapshot technology highly suitable for dynamic medical applications such as intraoperative guidance and emergency diagnostics. Moreover, the growing demand for portable and handheld devices is further accelerating the adoption of snapshot systems, as they are easier to integrate into compact medical platforms. As healthcare shifts toward real-time, non-invasive solutions, snapshot hyperspectral imaging emerges as the dominant driver in this segment.

Based on the application

• Medical Diagnostics
• Quality Assurance & Drug Testing
• Others

Among the application segments, medical diagnostics is anticipated to lead the market, as it represents the most impactful and widely adopted use of the technology. Hyperspectral imaging provides clinicians with the ability to detect and analyze subtle biochemical and structural changes in tissues that are often invisible to conventional imaging methods. This capability is particularly valuable in oncology, where HSI assists in identifying tumor margins and differentiating malignant from healthy tissues in real time, reducing the risk of incomplete resections. It is also gaining traction in ophthalmology for retinal disease assessment and in wound care for monitoring chronic ulcers and burns by measuring tissue oxygenation and perfusion. The rising global prevalence of chronic diseases and the growing emphasis on early and accurate diagnosis further accelerate the adoption of HSI in medical diagnostics. As precision medicine and non-invasive tools become priorities in healthcare, this segment stands out as the strongest driver of market growth.

Based on the end use

• Hospitals & Clinics
• Research & Academic Institutes
• Pharmaceutical and Biotechnology Companies

Within the end-use segmentation, hospitals and clinics are anticipated to lead the market, as they represent the primary centers where clinical adoption and patient-focused applications of this technology are taking place. Hospitals increasingly rely on hyperspectral imaging for intraoperative guidance, wound assessment, and non-invasive diagnostics, as it provides surgeons and physicians with real-time visualization of tissue oxygenation, perfusion, and disease margins. This capability improves surgical accuracy, reduces postoperative complications, and enhances patient outcomes. Clinics, on the other hand, are adopting portable and handheld hyperspectral systems for wound care, dermatology, and ophthalmology, expanding accessibility to advanced diagnostics beyond large institutions. The growing prevalence of cancer, diabetes, and vascular diseases is driving healthcare providers to seek technologies that support early detection and precision treatment, making hospitals and clinics the largest users. As integration with AI and decision-support tools advances, this segment is expected to remain the dominant force propelling market growth.